Neuberger Berman Group LLC Karyopharm Therapeutics Inc. Transaction History

Neuberger Berman Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.06 $16,065 - $24,328	-22,951 Closed	0 $0
Q2 2024 Nov 14, 2024	BUY	$0.87 - $1.58 $8,381 - $15,221	9,634 Added 72.34%	22,951 $19,000
Q2 2024 Aug 13, 2024	BUY	$0.87 - $1.58 $19,967 - $36,262	22,951 New	22,951 $19,000
Q4 2023 Nov 14, 2024	SELL	$0.68 - $1.31 $6,551 - $12,620	-9,634 Reduced 41.98%	13,317 $11,000
Q4 2023 Feb 09, 2024	BUY	$0.68 - $1.31 $1,416 - $2,728	2,083 Added 18.54%	13,317 $11,000
Q3 2023 Nov 14, 2023	BUY	$1.14 - $1.81 $12,806 - $20,333	11,234 New	11,234 $15,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $53.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.